XML 217 R58.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of financial assets
             
   December 31, 
   2022   2023   2023 
   CNY   CNY   US$ 
             
Debt instruments at amortized cost:               
Trade receivables: current   46,760         
Trade receivables: non-current   10,520         
Financial assets included in other receivables   82,406    3     
Financial assets at fair value through other comprehensive income:               
Bills receivable   8,500         
                
Total   148,186    3     
                
Total current   137,666    3     
Total non-current   10,520         
Schedule of financial liabilities
             
   December 31,   December 31,   December 31, 
   2022   2023   2023 
    CNY    CNY    US$ 
                
Derivatives not designated as hedging instruments:               
Derivative financial liabilities (i)   824         
Financial liabilities at amortized cost:               
Trade payables   20,326    100    14 
Financial liabilities in other payables and accruals   6,749    7,864    1,111 
Lease liabilities   2,915    360    51 
Due to related companies   3,408    9,069    1,281 
Due to the Shareholder   7,153    85,673    12,103 
Interest-bearing loans and borrowings   74,000         
                
Total   115,375    103,066    14,560 
                
Total current   42,777    103,066    14,560 
Total non-current   72,598         

 

 

(i)  

This represents certain warrants issued to institutional investors on January 20, 2021, which was recognized as derivative financial liabilities (not designated as hedging instruments) with a fair value of CNY9,246 (US$1,427)* on the issue date as the investors have the right to exercise their warrants on a cashless basis. In accordance with IAS 32, a contract settled by a single net payment (generally referred to as net cash-settled or net equity-settled as the case may be) is a financial liability and not an equity instrument. The fair value gain of derivative financial liabilities for the years ended December 31, 2021, 2022 and 2023 was CNY7,467 and CNY1,007, CNY847 (US$120), respectively.

 

Schedule of the carrying amounts and fair values of the Group’s financial instruments other than those with carrying amounts
                         
   December 31, 
   2022   2023   2023 
   CNY   CNY   US$ 
  

Carrying

amount

  

Fair

value

  

Carrying

amount

  

Fair

value

  

Carrying

amount

  

Fair

value

 
                               
Financial liabilities                              
Interest-bearing loans and borrowings   74,000    77,636                 
Schedule of the fair value measurement hierarchy of the Group’s financial assets and financial liabilities
                    
As of December 31, 2022  Fair value measurement using 
  

Quoted prices in active markets

(Level 1)

  

Significant observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

   Total 
   CNY   CNY   CNY   CNY 
Recurring fair value measurement:                    
Financial assets                    
Bills receivable       8,500        8,500 
Financial liabilities                    
Derivative financial liabilities       824        824